Search Results - "BEAUGERIE, L"

Low counts of Faecalibacterium prausnitzii in colitis microbiota by Sokol, H., Seksik, P., Furet, J.P., Firmesse, O., Nion‐Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P., Doré, J.

“…Background: The intestinal microbiota is suspected to play a role in colitis and particularly in inflammatory bowel disease (IBD) pathogenesis. The aim was to…”
Get full text

Quality of life of inflammatory bowel diseases patients in france with EQ-5D-5 L: the QALY-MICI study by Sarter, H, Kirschgesner, J, Beaugerie, L, Buisson, A, Gower-Rousseau, C, de Pouvourville, Gérard

“…This study aimed to document utility values and the Visual Analog Scale (VAS) with the 5-level version of the EQ-5D questionnaire in a large sample of patients…”
Get full text

Commentary: monitoring for myelosuppression in IBD by Beaugerie, L.

Get full text

Review article: drug‐induced microscopic colitis – proposal for a scoring system and review of the literature by BEAUGERIE, L., PARDI, D. S.

“…Summary The pathophysiology of microscopic colitis is unknown, although it is thought to be because of an abnormal immune reaction to luminal antigens in…”
Get full text

Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle by Sokol, H, Beaugerie, L

“…The risk of lymphoproliferative disorders (LDs) has become a major concern for clinicians managing patients with inflammatory bowel disease (IBD). Yet it is…”
Get more information

The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease by Delvincourt, M., Lopez, A., Pillet, S., Bourrier, A., Seksik, P., Cosnes, J., Carrat, F., Gozlan, J., Beaugerie, L., Roblin, X., Peyrin‐Biroulet, L., Sokol, H.

“…Summary Background Consequences of latent cytomegalovirus (CMV) infection reactivation on inflammatory bowel disease (IBD) flare, as a flare‐worsening factor…”
Get full text

Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery by Cosnes, J, Nion-Larmurier, I, Beaugerie, L, Afchain, P, Tiret, E, Gendre, J-P

“…Background/Aim: Immunosuppressants are now used much earlier in the course of Crohn’s disease; however their effect on the natural history of the disease,…”
Get full text

Early ileal resection in Crohn's disease is not associated with severe long‐term outcomes: The ERIC study by Grellier, Nathan, Kirchgesner, Julien, Uzzan, Mathieu, Mclellan, Paul, Stefanescu, Carmen, Lefèvre, Jérémie H., Treton, Xavier, Panis, Yves, Sokol, Harry, Beaugerie, Laurent, Seksik, Philippe

“…Summary Background Early complicated Crohn's disease (CD) may require ileal resection as first‐line treatment. Aim To evaluate the long‐term outcomes of…”
Get full text

Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease by Cosnes, J., Sokol, H., Bourrier, A., Nion‐Larmurier, I., Wisniewski, A., Landman, C., Marteau, P., Beaugerie, L., Perez, K., Seksik, P.

“…Summary Background The comparative efficacy of adalimumab (ADA) and infliximab (IFX) in Crohn's disease, and the benefit of initial combotherapy with an…”
Get full text

Risk of anti-TNF therapy on pregnancy, breastfeeding, live vaccines and related information in patients with inflammatory bowel disease: Real-world data from a nationwide study by Bendaoud, S., Nahon, S., Beaugerie, L., Gornet, J.M., Wils, P., Amiot, A., Peyrin-Biroulet, L., Abitbol, V., Hébuterne, X., Altwegg, R., Rosa, I., Amil, M., Heluwaert, F., Plastaras, L., Stefanescu, C., Quentin, V., Antoni, M., Bideau, K., Boualit, M., Cuillerier, E., Locher, C., Skinazi, F., Boureille, A., Buisson, A., Simon, M.

“…Anti-TNF are usually maintained during pregnancy in patients with inflammatory bowel disease (IBD) but safety is still a concern for them. To provide data on…”
Get full text

Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort Study by Poullenot, F, Amiot, A, Nachury, M, Viennot, S, Altwegg, R, Bouhnik, Y, Abitbol, V, Nancey, S, Vuitton, L, Peyrin-Biroulet, L, Biron, A, Fumery, M, Picon, L, Vidon, M, Reenaers, C, Serrero, M, Savoye, G, Beaugerie, L, Rivière, P, Laharie, D

“…Abstract Introduction Knowledge about the cancer risk when initiating a biologic in inflammatory bowel disease [IBD] patients with prior malignancy remains…”
Get full text

Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study by Martineau, C., Flourié, B., Wils, P., Vaysse, T., Altwegg, R., Buisson, A., Amiot, A., Pineton de Chambrun, G., Abitbol, V., Fumery, M., Hébuterne, X., Viennot, S., Laharie, D., Beaugerie, L., Nancey, S., Sokol, H., Abitbol, Vered, Altwegg, Romain, Amiot, Aurélien, Beaugerie, Laurent, Boschetti, Gilles, Bourrier, Anne, Buisson, Anthony, Carbonnel, Frank, Condat, Joris, Cosnes, Jacques, Flourié, Bernard, Fumery, Mathurin, Hébuterne, Xavier, Kirchgesner, Julien, Laharie, David, Landman, Cécilia, Loreau, Julien, Marteau, Philippe, Martineau, Chloé, Mille, Fréderic, Nancey, Stéphane, Nion‐Larmurier, Isabelle, Pineton de Chambrun, Guillaume, Nachury, Maria, Pariente, Benjamin, Seksik, Philippe, Sokol, Harry, Vaysse, Thibaut, Viennot, Stéphanie, Wils, Pauline

“…Summary Background Anti‐tumour necrosis factor (TNF) agents have improved the care of Crohn's disease (CD). After the first anti‐TNF discontinuation, it is…”
Get full text

Effect of Antibiotic Therapy on Human Fecal Microbiota and the Relation to the Development of Clostridium difficile by De La Cochetière, M. F, Durand, T, Lalande, V, Petit, J. C, Potel, G, Beaugerie, L

“…The gastrointestinal tract is a complex ecosystem. Recent studies have shown that the human fecal microbiota is composed of a consortium of microorganism. It…”
Get full text

Overexpression of microRNAs-155 and 21 targeting mismatch repair proteins in inflammatory bowel diseases by Svrcek, Magali, El-Murr, Nizar, Wanherdrick, Kristell, Dumont, Sylvie, Beaugerie, Laurent, Cosnes, Jacques, Colombel, Jean-Frédéric, Tiret, Emmanuel, Fléjou, Jean-François, Lesuffleur, Thécla, Duval, Alex

“…Microsatellite instability (MSI) due to mismatch repair (MMR) deficiency is reported in 5-10% of colorectal cancers (CRCs) complicating inflammatory bowel…”
Get full text

Prognosis of Lymphoma in Patients With Known Inflammatory Bowel Disease: A French Multicentre Cohort Study by Severyns, T, Kirchgesner, J, Lambert, J, Thieblemont, C, Amiot, A, Abitbol, V, Treton, X, Cazals-Hatem, D, Malamut, G, Coppo, P, Galicier, L, Walter-Petrich, A, Deau-Fischer, B, Besson, C, Aparicio, T, Beaugerie, L, Allez, M, Gornet, J M

“…Abstract Background and Aims The prognosis of lymphoma that occurs in patients with inflammatory bowel disease [IBD] is poorly known. Methods A multicentre…”
Get full text

Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort by Vienne, A., Simon, T., Cosnes, J., Baudry, C., Bouhnik, Y., Soulé, J. C., Chaussade, S., Marteau, P., Jian, R., Delchier, J.‐C., Coffin, B., Admane, H., Carrat, F., Drouet, E., Beaugerie, L.

“…Aliment Pharmacol Ther 2011; 34: 188–195 Summary Background  Surveillance colonoscopy is recommended for inflammatory bowel disease (IBD) patients with…”
Get full text

Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum by Thiéfin, Gérard, Beaugerie, Laurent

“…The gastrointestinal toxicity of conventional nonsteroidal antiinflammatory drugs (NSAIDs) is not confined to the stomach and proximal duodenum but extends…”
Get full text

Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprine by SEKSIK, P., COSNES, J., SOKOL, H., NION‐LARMURIER, I., GENDRE, J.‐P., BEAUGERIE, L.

“…Summary Background  There are few data on the incidence of benign infections (upper respiratory tract infections, herpes lesions and viral warts) during…”
Get full text

Impact of the diagnosis and treatment of cancer on the course of inflammatory bowel disease by Rajca, S., Seksik, P., Bourrier, A., Sokol, H., Nion-Larmurier, I., Beaugerie, L., Cosnes, J.

“…The effects of extra-intestinal cancer on the course of inflammatory bowel disease (IBD) are poorly understood. To evaluate the impact of cancer and its…”
Get full text

Crohn's disease clinical course and severity in obese patients by BLAIN, A., CATTAN, S., BEAUGERIE, L., CARBONNEL, F., GENDRE, J.P., COSNES, J.

“…Background and aims: Obesity is unusual in Crohn's disease and the particularities of the disease in obese patients have not been studied. Methods: 2065…”
Get full text